Shear-wave Elastography Compared to Respiratory Function Testing
Comparison of Shear-wave Elastography to State-of-the-art Respiratory Function Testing to Measure the Range of Forces Generated by the Diaphragm Muscle
1 other identifier
interventional
24
1 country
1
Brief Summary
The purpose of this study is to evaluate the relationship between transdiaphragmatic pressure (Pdi) and diaphragm shear-wave elastography (SWE) during state-of-the-art respiratory muscle testing including volitional efforts (e.g., maximal inspiratory pressure, maximal expiratory pressure, Valsalva maneuver), as well as maximal phrenic nerve stimulation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 2, 2021
CompletedFirst Posted
Study publicly available on registry
July 13, 2021
CompletedStudy Start
First participant enrolled
July 28, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
March 16, 2026
March 1, 2026
5.3 years
July 2, 2021
March 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Shear wave speed
Elastography of the diaphragm muscle across various behaviors and conditions
3 hours
Study Arms (1)
Respiratory Function Testing
EXPERIMENTALAll subjects will receive standard respiratory function testing and ultrasound-based elastography measurements across various behaviors and conditions
Interventions
Ultrasound based imaging of diaphragm muscle activity
Eligibility Criteria
You may qualify if:
- \- Adult male and female healthy volunteers.
You may not qualify if:
- Volunteers who are pregnant.
- Volunteers with known pulmonary pathology (COPD, asthma requiring routine treatment).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (1)
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Carlos Matilla, MD, PhD
Mayo Clinic
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 2, 2021
First Posted
July 13, 2021
Study Start
July 28, 2021
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
March 16, 2026
Record last verified: 2026-03